Literature DB >> 22153664

Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.

Brooke E Gilliam1, Melinda R Reed, Anil K Chauhan, Amanda B Dehlendorf, Terry L Moore.   

Abstract

OBJECTIVES: Immune complexes (ICs) from sera of juvenile idiopathic arthritis (JIA) patients show increased complement opsonisation; however, a definitive role for involvement of the classical or alternative pathway is not entirely clear. To delineate the role of these pathways, we measured activated complement products bound to circulating IC (CICs) in the sera of JIA patients.
METHODS: Sera from 100 JIA patients and 22 healthy children were collected. C1q, C4, C3, C3d, and membrane attack complex (MAC) bound to CICs were measured by enzyme-linked immunosorbent assay. Data was compared to IgM rheumatoid factor (RF), IgG anti-cyclic citrullinated peptide (CCP) antibodies, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) levels.
RESULTS: Mean levels of C1q, C4, and MAC bound to CICs were significantly elevated in JIA patients compared to healthy children. C1q correlated significantly with C4 and MAC bound to CICs and C4 and MAC also demonstrated significant correlation. No significant differences were noted in complement components bound to CICs when evaluating IgM RF, anti-CCP antibody, and CRP positivity. A significant correlation was noted between MAC bound to CICs and ESR. C1q and MAC bound to CICs mean levels were significantly higher in patients with an elevated ESR compared to those with a normal ESR level.
CONCLUSIONS: JIA patients have elevated levels of complement components bound to CICs, particularly from the classical pathway. Moreover, classical pathway components were associated with ESR, a marker of disease activity. MAC bound to CICs also correlated significantly with ESR, further supporting the notion of complement-mediated tissue injury that is triggered by IC-mediated classical pathway activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153664

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

1.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

2.  Hypocomplementemia during tocilizumab treatment: Long-term follow-up results.

Authors:  Amir Bieber; Doron Markovits; Kohava Toledano; Yonit Tavor; Reuven Mader; Alexandra Balbir-Gurman; Yolanda Braun-Moscovici
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

3.  Serum C1q concentration is associated with disease activity in Chinese Takayasu arteritis patients: A case-control study.

Authors:  Si Chen; Haixia Luan; Jianxun He; Yan Wang; Xiaoli Zeng; Yongzhe Li; Hui Yuan
Journal:  Health Sci Rep       Date:  2021-03-23

Review 4.  Immune Complexes in Juvenile Idiopathic Arthritis.

Authors:  Terry L Moore
Journal:  Front Immunol       Date:  2016-05-20       Impact factor: 7.561

5.  Primary complement and antibody deficiencies in autoimmune rheumatologic diseases with juvenile onset: a prospective study at two centers.

Authors:  Mihaela Spârchez; Iulia Lupan; Dan Delean; Aurel Bizo; Laura Damian; Laura Muntean; Maria Magdalena Tămaș; Claudia Bolba; Bianca Simionescu; Cristina Slăvescu; Ioana Felea; Călin Lazăr; Zeno Spârchez; Simona Rednic
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-21       Impact factor: 3.054

6.  Expression of C1q in the serum of patients with non‑severe aplastic anemia, and its association with disease severity.

Authors:  Shaoxue Ding; Chunyan Liu; Yang Li; Hui Liu; Zhaoyun Liu; Tong Chen; Tian Zhang; Zonghong Shao; Rong Fu
Journal:  Mol Med Rep       Date:  2018-12-12       Impact factor: 2.952

Review 7.  Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.

Authors:  Shawn A Mahmud; Bryce A Binstadt
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

Review 8.  Update and review of the gerodontology prospective for 2020's: Linking the interactions of oral (hypo)-functions to health vs. systemic diseases.

Authors:  Yen Chun G Liu; Shou-Jen Lan; Hirohiko Hirano; Li-Min Lin; Kazuhiro Hori; Chia-Shu Lin; Samuel Zwetchkenbaum; Shunsuke Minakuchi; Andy Yen-Tung Teng
Journal:  J Dent Sci       Date:  2020-10-17       Impact factor: 2.080

Review 9.  B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

Authors:  Rita A Moura; João Eurico Fonseca
Journal:  Front Med (Lausanne)       Date:  2022-04-04

10.  Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.

Authors:  Mia Glerup; Steffen Thiel; Veronika Rypdal; Ellen Dalen Arnstad; Maria Ekelund; Suvi Peltoniemi; Kristiina Aalto; Marite Rygg; Susan Nielsen; Anders Fasth; Lillemor Berntson; Ellen Nordal; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2019-09-09       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.